Cover |
I |
contents |
2 |
Foreword |
4 |
1 Policy and Organization |
6 |
Section 1. Policy Objectives and Focus Areas |
7 |
Section 2. Organization Framework |
9 |
Section 3. Future Prospects |
11 |
2 Food Management |
12 |
Section 1 Food Laws, Regulations, and Standards, and Product Reviews |
13 |
Section 2 Food Product Source Management |
15 |
Section 3 Food Product Safety Chain Monitoring |
19 |
Section 4 Food Safety and Sanitation Management |
21 |
3 Medicinal Products Management |
24 |
Section 1 Medicinal Product Regulations and Registration |
25 |
Section 2 Medicinal Products Source Management |
28 |
Section3 Medicinal Products Quality Chain Monitoring |
31 |
Section 4 Medicinal Products Safety Management |
34 |
4 Controlled Drug Management |
36 |
Section 1. Controlled Drugs Regulations and Distribution Management |
37 |
Section 2. Management of Pharmaceutical Plant of Controlled Drugs |
40 |
Section 3. Controlled Drug Alerts and Monitoring |
41 |
Section 4. Controlled Drug Abuse Prevention |
43 |
5 Medical Devices Management |
44 |
Section 1 Medical Device Regulations and Product Review |
45 |
Section 2 Medical Devices Source Management |
48 |
Section 3 Medical Device Quality Chain Monitoring |
49 |
Section 4 Medical Device Safety Management |
51 |
6 Cosmetics Management |
54 |
Seciton 1 Cosmetics Regulations and Product Review |
55 |
Section 2 Cosmetics Source Management |
59 |
Section 3 Cosmetics Quality Chain Monitoring |
60 |
Section 4 Cosmetics Safety Management |
62 |
7 Risk Assessment Management and Research Outcomes |
64 |
Section 1 Risk Assessment |
65 |
Section 2 Risk Management and Emergency Response Mechanism |
72 |
Section 3. Research Outcomes |
75 |
8 National Laboratory and Testing Network |
78 |
Section 1 Mission of the National Laboratory |
79 |
Section 2 Strengthening the Testing Capability of National and Local Laboratories |
81 |
Section 3 Comprehensive Private Laboratory Accreditation and Management System |
86 |
Section 4 Comprehensive Mobilization for Emergency Testing |
90 |
9 International Cooperation and Cross-Strait Exchange |
92 |
Section 1. International Cooperation and Exchange |
93 |
Section 2. Globalization of Laboratory Testing |
98 |
Section 3. Cross-Strait Exchange |
99 |
10 Risk Communication and Consumer Protection |
104 |
Section 1 Providing Consumers with Immediate Information |
105 |
Section 2 Consumer Communication and Advocacy |
107 |
Appendix |
112 |
Appendix 1. Significant Accomplishments and Statistics |
113 |
Appendix 2. Publications of 2014 |
126 |
Appendix 3. Website Links |
127 |